OTO: Time-Driven Activity-Based Cost Comparison of Thyroid Lobectomy and Radiofrequency Ablation
30m
·
OTO Journal
·
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by Associate Editor Raymond L. Chai, MD, and lead author Julia E. Noel, MD, to discuss “Time-Driven Activity-Based Cost Comparison of Thyroid Lobectomy and Radiofrequency Ablation,” which published in the October 2023 issue ofOtolaryngology–Head and Neck Surgery. Dr. Noel and her coauthors used time-driven activity-based cost methodology to drill down the details that reveal radiofrequency ablation (RFA) is a more cost-effective treatment modality. They looked at the entire treatment cycle for both lobectomy and RFA— from initial visit in clinic through the procedure and postoperative visit—to determine cost data for the hospital.
The episode OTO: Time-Driven Activity-Based Cost Comparison of Thyroid Lobectomy and Radiofrequency Ablation from the podcast OTO Journal has a duration of
30:11. It was first published
More episodes from OTO Journal
OTO: Clinical Practice Guideline: Age-Related Hearing Loss Part 2
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead authors Heather M. Weinreich, MD, MPH and Carrie L. Nieman, MD, MPH to provide a patient and primary care provider-focused overview of the “Clinical Practice Guideline: Age-Related Hearing Loss” which published in the May 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss the pearls and pitfalls in screening and treating hearing loss for the patient and non-otolaryngologist providers.
Click here to read the full article.
OTO: Clinical Practice Guideline: Age-Related Hearing Loss Part 1
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead authors Betty S. Tsai Do, MD, and Matthew L. Bush MD, PhD, MBA, for a discussion of some key points of the “Clinical Practice Guideline: Age-Related Hearing Loss” which published in the May 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss the recommendations for screening of hearing loss and the pros and cons for different treatment options of age-related hearing loss.
Click here to read the full article.
OTO: Otolaryngology Applicant Perspectives on In-person and Virtual Residency Interviews
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Anne C. Kane, MD, and Associate Editor Michael J. Brenner, MD for a discussion of the article “Otolaryngology Applicant Perspectives on In-person and Virtual Residency Interviews", which published in the April 2024 issue of Otlaryngology-Head and Neck Surgery. They discuss the pros and cons of conducting residency interviews either in-person or virtually, including the impacts of in-person interviews on underrepresented applicants.
Click here to read the full article.
OTO: Clinical Practice Guideline: Immunotherapy for Inhalant Allergy, Part 2
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by authorCecelia C Damask, DOand authorChristine M. Reger, DNP, CRNP for a discussion of the implications for non-otolaryngologists of the “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy,” which published in the March 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss how allergies impact patients' lives and how immunotherapy can improve their symptoms.
Click here to read the full article.
OTO: Clinical Practice Guideline: Immunotherapy for Inhalant Allergy, Part 1
Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead author Richard K. Gurgel, MD, MSC, and author Stacey L. Ishman, MD, MPH for a discussion of the implications for otolaryngologists of the “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy,” which published in the March 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss how the CPG came together over two years and what they discovered comparing different types of immunotherapy and the effects on different patient populations.
Click here to read the full article.